GlobeNewswire
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation
📈
AI Sentiment
Highly Positive
8/10
Jasper Therapeutics Inc. News
Latest updates and market news for JSPR
2 news
Nov 27 - Dec 3, 2025
Page 1
GlobeNewswire
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation
📊
AI Sentiment
Positive
6/10
Share this news page